Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Leiah Brigitha

Leiah Brigitha
Leiah Brigitha
Asparaginase treatment in children with acute lymphoblastic leukemia
Phone 088 97 29 000
  • Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL

    • feb. 2024
    • Inge M, van der Sluis, et al
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Higher incidence of delayed methotrexate clearance in pediatric acute lymphoblastic leukemia patients treated with imatinib

    • jan. 2023
    • Inge, van der Sluis, et al
    • EJC Pediatric Oncology
  • Safety of mRNA-based COVID-19 vaccination in paediatric patients with a PEG-asparaginase allergy

    • jan. 2023
    • Nancy, Broos, et al
    • EJC Pediatric Oncology
  • Depletion of d- and l-asparagine in cerebrospinal fluid in acute lymphoblastic leukemia during PEGasparaginase therapy

    • nov. 2022
    • Leiah J., Brigitha, et al
    • Pediatric Blood and Cancer
  • Hypersensitivity to Pegylated E.coli sparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols

    • feb. 2022
    • , et al
    • European Journal of Cancer
View all publications